COMMUNIQUÉS West-GlobeNewswire

-
RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations
20/02/2019 -
BioSig Announces Successful First-In-Human Use of PURE EP System
20/02/2019 -
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
20/02/2019 -
FIT Biotech Oy: Liquidity crisis, request for a tranche and changes to financial calendar and date of the Annual General Meeting
20/02/2019 -
Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development
20/02/2019 -
Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference
20/02/2019 -
Harpoon Therapeutics to Present at SVB Leerink Global Healthcare Conference
20/02/2019 -
Kura Oncology to Present at SVB Leerink Global Healthcare Conference
20/02/2019 -
Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity
20/02/2019 -
Marinus Pharmaceuticals to Present at the Leerink Healthcare Conference
20/02/2019 -
ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
20/02/2019 -
Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions
20/02/2019 -
Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019
20/02/2019 -
Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory Epilepsy
20/02/2019 -
PotBotics: Bringing Big Data to Medical Cannabis -- CFN Media
20/02/2019 -
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2018
20/02/2019 -
Acarix Year-End Report 2018: Market dynamics favourable for CADScor®System, addressing the challenges of the global healthcare market
20/02/2019 -
Verona Pharma to Announce Financial Results for Full Year ended December 31, 2018 and Provide Clinical Development Update
20/02/2019 -
Neovacs announces two appointments to its executive committee
20/02/2019
Pages